<DOC>
	<DOCNO>NCT02945176</DOCNO>
	<brief_summary>The ARGOS-IO pressure sensor intend implanted human eye combination Boston Keratoprosthesis ( BKPro ) surgery remain place indefinitely . It intend use together hand-held Mesograph reading device telemetrically measure intraocular pressure ( IOP ) patient BKPro . The purpose study evaluate safety performance ARGOS-IO system patient undergo concomitant implantation BKPro ARGOS-IO sensor 12 month period begin implantation .</brief_summary>
	<brief_title>Safety Performance Study ARGOS-IO System Patients Undergoing Boston Keratoprosthesis Implantation</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Stevens-Johnson Syndrome</mesh_term>
	<mesh_term>Aniridia</mesh_term>
	<mesh_term>Hydrophthalmos</mesh_term>
	<mesh_term>Burns , Chemical</mesh_term>
	<criteria>1 . Male female age ≥ 18 ≤ 80 year day screen 2 . Keratoprosthesis surgery indicate , define severely opaque vascularize cornea AND either verifiable history two prior fail corneal transplant procedure medical condition alkali burn autoimmune disease make success traditional corneal transplant procedure unlikely . Potential study subject solicit participation clinical trial consent keratoprosthesis operation . 3 . Axial length &gt; 21 mm 4 . Ability willingness attend schedule visit comply study procedure 1 . Reasonable chance success traditional keratoplasty 2 . Current retinal detachment 3 . Connective tissue diseases 4 . History evidence severe inflammatory eye disease ( i.e . uveitis , retinitis , scleritis ) one eye within 6 month prior ARGOSIO implantation 5 . History ocular periocular malignancy 6 . History extensive keloid formation 7 . Any known intolerance hypersensitivity topical anesthetic , mydriatic , silicone ( component device ) 8 . Presence another active medical eye implant and/or active medical implant head/neck region 9 . Signs current infection , include fever current treatment antibiotic 10 . Severe generalized disease result life expectancy short year 11 . Any clinical evidence investigator feel would place subject increase risk placement device 12 . Currently pregnant breastfeed 13 . Participation study involve investigational drug device within past 30 day ongoing participation study investigational drug device 14 . Intraoperative complication would preclude implantation study device 15 . Subject and/or immediate family member employee investigational site directly affiliate study , sponsor contract research organization . Previous concurrent enrollment contralateral eye clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Boston Keratoprosthesis</keyword>
</DOC>